India to United States: Liraglutide Export Trade Route
India has recorded 64 verified shipments of Liraglutide exported to United States, representing a combined trade value of $30.8K USD. This corridor is served by 11 active Indian exporters, with an average shipment value of $481 USD. The leading Indian exporter is LUPIN LIMITED, which accounts for 90% of total export value with 2 shipments worth $27.6K USD. On the buying side, DR,ANTHONY ANDRE, is the largest importer in United States with $27.6K USD in purchases. The top 3 suppliers — LUPIN LIMITED, MYGENIC HEALTHCARE PRIVATE LIMITED, ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI — together control 99% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Liraglutide corridor is one of India's established pharmaceutical export routes, with 64 shipments documented worth a combined $30.8K USD. The route is dominated by LUPIN LIMITED, which alone accounts for roughly 90% of all export value, reflecting the consolidated nature of India's liraglutide manufacturing sector.
Across 11 active suppliers, the average shipment value stands at $481 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with liraglutide's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 15.5%, placing it at rank #6 among India's top liraglutide export destinations globally.
On the import side, key buyers of Indian liraglutide in United States include DR,ANTHONY ANDRE,, JULIO MAGALLON GARCIA, PHARMATHEN and 20 others. DR,ANTHONY ANDRE, is the single largest importer with 2 shipments valued at $27.6K USD.
Route Characteristics
- Average transit25 days
- Peak seasonQ1
- Primary modeSea freight
- Top portHAZIRA PORT SURAT ICD
Market Position
- Global rank#6
- Annual growth+15.5%
- Demand growth+15.3%
- Regulatory ease73/100
Top 10 Indian Liraglutide Exporters to United States
Showing top 10 of 11 Indian suppliers exporting Liraglutide to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LUPIN LIMITED Avg $13.8K per shipment | 2 | $27.6K | 89.7% |
| 2 | MYGENIC HEALTHCARE PRIVATE LIMITED Avg $2.5K per shipment | 1 | $2.5K | 8.1% |
| 3 | ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI Avg $10 per shipment | 23 | $219 | 0.7% |
| 4 | VEEDA CLINICAL RESEARCH LIMITED Avg $80 per shipment | 2 | $159 | 0.5% |
| 5 | STELIS BIOPHARMA LIMITED Avg $41 per shipment | 2 | $83 | 0.3% |
| 6 | DR.REDDY'S LABORATORIES LIMITED Avg $12 per shipment | 6 | $75 | 0.2% |
| 7 | DR REDDYS LABORATORIES LIMITED Avg $73 per shipment | 1 | $73 | 0.2% |
| 8 | ZYDUS LIFESCIENCES LIMITED Avg $1 per shipment | 22 | $21 | 0.1% |
| 9 | DR.REDDY'S LABORATORIES LTD Avg $5 per shipment | 3 | $14 | 0.0% |
| 10 | EXTROVIS PRIVATE LIMITED Avg $12 per shipment | 1 | $12 | 0.0% |
This table shows the top 10 of 11 Indian companies exporting liraglutide to United States, ranked by total trade value. The listed exporters are: LUPIN LIMITED, MYGENIC HEALTHCARE PRIVATE LIMITED, ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI, VEEDA CLINICAL RESEARCH LIMITED, STELIS BIOPHARMA LIMITED, DR.REDDY'S LABORATORIES LIMITED, DR REDDYS LABORATORIES LIMITED, ZYDUS LIFESCIENCES LIMITED, DR.REDDY'S LABORATORIES LTD, EXTROVIS PRIVATE LIMITED. LUPIN LIMITED is the dominant supplier with 2 shipments worth $27.6K USD, giving it a 90% market share. The top 3 suppliers together account for 99% of the total trade value on this route.
Showing top 10 of 11 total Indian exporters on the India to United States Liraglutide export route.
Top 10 Liraglutide Importers in United States
Showing top 10 of 23 known buyers in United States receiving Liraglutide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian liraglutide in United States include DR,ANTHONY ANDRE,, JULIO MAGALLON GARCIA, PHARMATHEN, ZEBRASCI INC, EUROFINS LANCASTER LABORATORIES INC, among 23 total buyers. The largest importer is DR,ANTHONY ANDRE,, accounting for $27.6K USD across 2 shipments — representing 90% of all liraglutide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DR,ANTHONY ANDRE, | 2 | $27.6K | 89.7% |
| 2 | JULIO MAGALLON GARCIA | 1 | $2.5K | 8.1% |
| 3 | PHARMATHEN | 2 | $159 | 0.5% |
| 4 | ZEBRASCI INC | 2 | $85 | 0.3% |
| 5 | EUROFINS LANCASTER LABORATORIES INC | 2 | $83 | 0.3% |
| 6 | M S HTL BIO SOLUTIONS INC | 8 | $60 | 0.2% |
| 7 | FOCUS ON BOSTON | 2 | $54 | 0.2% |
| 8 | M/S.LONZA BIOLOGICS | 4 | $48 | 0.2% |
| 9 | M/S.HTL BIO SOLUTIONS INC | 3 | $36 | 0.1% |
| 10 | MS HTL BIO SOLUTIONS INC | 1 | $30 | 0.1% |
Showing top 10 of 23 Liraglutide importers in United States on this route.
Top 10 Liraglutide Formulations Imported by United States
Showing top 10 of 49 product formulations shipped on the India to United States Liraglutide route, ranked by trade value
United States imports a wide range of liraglutide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — SAXENDA (LIRAGLUTIDE) INJECTION#(BATCH NO:PZF8W58) — accounts for $26.9K USD across 1 shipments. There are 49 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SAXENDA (LIRAGLUTIDE) INJECTION#(BATCH NO:PZF8W58) | 1 | $26.9K | 87.5% |
| 2 | Victoza Liraglutide Pen | 1 | $2.5K | 8.1% |
| 3 | LIRAGLUTIDE INJECTION 18MG/3ML (6.0MG/ML) BATCH NO-N223007 | 1 | $690 | 2.2% |
| 4 | LIRAGLUTIDE SOLUTION INJECTION IN PRE FILED PEN 6MG/ML ( 8 PEN FILLED + 12 USEDPEN )DOSE TO SUBJECT ,BACK SPONSOR,NCV | 1 | $80 | 0.3% |
| 5 | LIRAGLUTIDE SOLUTION INJECTION IN PRE FILED PEN 6MG/ML (VICTOZA ) ( 8 PEN FILLED + 12 USED PEN ) ,BACK SPONSOR,NCV | 1 | $80 | 0.3% |
| 6 | LIRAGLUTIDE 6MG/ML SOLUTION FOR INJECTION 5DQTY:50 NOSFOR TESTING USE SAMPLESONLY | 1 | $73 | 0.2% |
| 7 | LIRAGLUTIDE INJECTION 18MG/3ML (6MG/ML)NOS | 3 | $56 | 0.2% |
| 8 | LIRAGLUTIDE INJECTION 6 MG/ ML, 1.8 MGPRE-FILLED PENS, 3S PACK BATCH NO:7000232A,7000233A,7000237A (QTY 60 PCKS) | 1 | $41 | 0.1% |
| 9 | LIRAGLUTIDE INJECTION 6 MG/ ML, 3.0 MGPRE-FILLED PENS, 5S PACK BATCH NO:7000235A,7000232B,7000237B (QTY 60 PCKS) | 1 | $41 | 0.1% |
| 10 | LIRAGLUTIDE INJECTION 6MG/ML | 3 | $36 | 0.1% |
Showing top 10 of 49 Liraglutide formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 72%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
HAZIRA PORT SURAT ICD handles the highest volume with 22 shipments. Transit time averages 25 days by sea.
Market Dynamics
India's liraglutide exports to United States are driven primarily by a handful of large-scale manufacturers. LUPIN LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 11 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — LUPIN LIMITED, MYGENIC HEALTHCARE PRIVATE LIMITED, ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI — together account for 99% of total trade value on this route. The average shipment value of $481 USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as victoza liraglutide pen and liraglutide injection 18mg/3ml (6.0mg/ml) batch no-n223007, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, DR,ANTHONY ANDRE, is the largest importer with 2 shipments worth $27.6K USD — representing 90% of all liraglutide imports from India on this route. A total of 23 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $30.8K
- Avg. Shipment
- $481
- Suppliers
- 11
- Buyers
- 23
- Transit (Sea)
- ~25 days
- Annual Growth
- +15.5%
Related Analysis
Reverse Direction
United States → India — Liraglutide (Import)Other Liraglutide Routes
Unlock the Full India to United States Liraglutide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 64 shipments on this route.
Frequently Asked Questions — India to United States Liraglutide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Liraglutide to United States?
The leading Indian exporters of Liraglutide to United States are LUPIN LIMITED, MYGENIC HEALTHCARE PRIVATE LIMITED, ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI. LUPIN LIMITED holds the largest market share at approximately 90% of total trade value on this route.
Q What is the total value of Liraglutide exports from India to United States?
India exports Liraglutide to United States worth approximately $30.8K USD across 64 recorded shipments. The average value per shipment is $481 USD.
Q Which ports does India use to ship Liraglutide to United States?
The most active port of origin is HAZIRA PORT SURAT ICD with 22 shipments. Indian exporters primarily use sea freight for this route, with 72% of shipments going by sea and 20% by air.
Q How long does shipping take from India to United States for Liraglutide?
The average transit time for Liraglutide shipments from India to United States is approximately 25 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to United States Liraglutide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 15.5% with demand growth tracking at 15.3%. The route is ranked #6 among India's top Liraglutide export destinations globally.
Q How many suppliers are active on the India to United States Liraglutide route?
There are currently 11 active Indian suppliers exporting Liraglutide to United States. The market is moderately concentrated with LUPIN LIMITED accounting for 90% of total shipment value.
Q Who are the main importers of Liraglutide from India in United States?
The leading importers of Indian Liraglutide in United States include DR,ANTHONY ANDRE,, JULIO MAGALLON GARCIA, PHARMATHEN, ZEBRASCI INC, EUROFINS LANCASTER LABORATORIES INC. DR,ANTHONY ANDRE, is the largest buyer with 2 shipments worth $27.6K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Liraglutide.
- 2.Supplier/Buyer Matching: 11 Indian exporters and 23 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 64 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
64 Verified Shipments
11 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists